Daré Bioscience(DARE) - 2025 Q4 - Annual Results

FOR IMMEDIATE RELEASE March 26, 2026 DARÉ BIOSCIENCE, INC. Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update Company Highlights Commercial Launch of DARE to PLAY™ Sildenafil Cream, Pipeline of Women's Health Solutions, and Multiple Near-Term Potential Catalysts Conference Call and Webcast Today at 4:30 p.m. ET SAN DIEGO, CA, March 26, 2026 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in ...